The mechanisms that link altered metabolism and heart failure remain unclear. A new study defines the role of the lysine demethylase KDM8 in preventing the initiation of dilated cardiomyopathy through epigenetic control of homeostatic cardiac metabolism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yu, J., Zeng, C. & Wang, Y. Curr. Opin. Cardiol. 34, 260–269 (2019).
Berry, J. M., Cao, D. J., Rothermel, B. A. & Hill, J. A. Expert Opin. Drug Saf. 7, 53–67 (2008).
Papait, R., Serio, S. & Condorelli, G. Physiol. Rev. 100, 1753–1777 (2020).
Hyun, K., Jeon, J., Park, K. & Kim, J. Exp. Mol. Med. 49, e324 (2017).
Hsia, D. A. et al. Proc. Natl Acad. Sci. USA 107, 9671–9676 (2010).
Wang, H. J. et al. Oncogene 38, 17–32 (2019).
Ahmed, A. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-023-00214-0 (2023).
Keating, S. T. & El-Osta, A. Circ. Res. 116, 715–736 (2015).
Yu, J. R. et al. Sci. Adv. 7, eabg7444 (2021).
Pepin, M. E. et al. Lab. Invest. 99, 371–386 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Bakshi, S., Wende, A.R. KDM8 prevents heart failure by controlling cardiac metabolism. Nat Cardiovasc Res 2, 106–107 (2023). https://doi.org/10.1038/s44161-023-00229-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-023-00229-7